SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis

  • Shuchi Anand
    Department of Medicine (Nephrology), Stanford University, Palo Alto, California (S.A., M.E.M., J.H., P.G.)
  • Maria E. Montez-Rath
    Department of Medicine (Nephrology), Stanford University, Palo Alto, California (S.A., M.E.M., J.H., P.G.)
  • Jialin Han
    Department of Medicine (Nephrology), Stanford University, Palo Alto, California (S.A., M.E.M., J.H., P.G.)
  • Pablo Garcia
    Department of Medicine (Nephrology), Stanford University, Palo Alto, California (S.A., M.E.M., J.H., P.G.)
  • LinaCel Cadden
    Ascend Clinical Laboratory, Redwood City, California (L.C., P.H., C.M., R.K., P.B.)
  • Patti Hunsader
    Ascend Clinical Laboratory, Redwood City, California (L.C., P.H., C.M., R.K., P.B.)
  • Curt Morgan
    Ascend Clinical Laboratory, Redwood City, California (L.C., P.H., C.M., R.K., P.B.)
  • Russell Kerschmann
    Ascend Clinical Laboratory, Redwood City, California (L.C., P.H., C.M., R.K., P.B.)
  • Paul Beyer
    Ascend Clinical Laboratory, Redwood City, California (L.C., P.H., C.M., R.K., P.B.)
  • Mary Dittrich
    U.S. Renal Care, Plano, Texas (M.D.)
  • Geoffrey A. Block
    U.S. Renal Care, Golden, Colorado (G.A.B.)
  • Glenn M. Chertow
    Departments of Medicine (Nephrology) and Epidemiology and Population Health, Stanford University, Stanford, California (G.M.C.)
  • Julie Parsonnet
    Departments of Medicine (Infectious Diseases and Geographic Medicine) and Epidemiology and Population Health, Stanford University, Stanford, California (J.P.).

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1360579820403789568
  • DOI
    10.7326/m21-4176
  • ISSN
    15393704
    00034819
  • データソース種別
    • Crossref

問題の指摘

ページトップへ